Saturday, June 7, 2008

Registration Open
SDCC: Hall B1 Lobby

Concurrent Breakfast Sessions

B5: Carotid Angioplasty and Stenting: Current Status
SDCC: Room 6C

Supported by an educational grant from Abbott Vascular and Cordis, Cardiac & Vascular Institute.

Moderator: Ronald M. Fairman, MD
Hospital of the University of Pennsylvania, Philadelphia, Pa.

At the end of this session, participants should be able to:
1. Review clinical trial results of carotid artery stenting.
2. Recognize predictors of outcome in order to optimize results of carotid stenting.
3. Understand the current CMS coverage policy. 

7:00 am 
Meta-analysis of Carotid Trials
Louis L. Nguyen, MD, Brigham and Women’s Hospital, Boston, Mass.

7:15 am
CREST, ACT 1, SPACE and EVA-3-S: Randomized Trials
Jon S. Matsumura, MD, Northwestern Memorial Hospital, Chicago, Ill.

7:30 am 
Incidence, Timing, Distribution and Severity of Stroke Following Carotid Stenting: Analysis of U.S. IDE/PMS Registry Data
Ronald M. Fairman, MD, Hospital of the University of Pennsylvania, Philadelphia, Pa.

7:45 am 
Strategies for Improving Current Results of Carotid Stenting
Peter L. Faries, MD, Mount Sinai School of Medicine, New York, N.Y. 

8:00 am 
Update on CMS Coverage for Carotid Stenting
Robert M. Zwolak, MD, Dartmouth-Hitchcock Medical Center, Lebanon, N.H.

8:15 am
Panel Discussion

Supported by an educational grant from W.L. Gore & Associates, Inc.

Moderator: Roy K. Greenberg, MD
Cleveland Clinic Foundation, Cleveland, Ohio  

At the end of this session, participants should be able to:
1. Identify the risk factors and methods of identifying stentgraft migration.
2. Identify the risk factors and treatment options for retrograde aortic dissection.
3. Identify the risk factors, treatment options and complications associated with proximal endoleak following TEVAR.
4. Identify issues related to iliac access for TEVAR.

7:00 am
Stentgraft Migration
Tara M. Mastracci, MD, Cleveland Clinic Foundation, Cleveland, OH

7:18 am
Retrograde Dissection
Ali Azizzadeh, MD, University of Texas Medical School, Houston, TX

7:36 am
Proximal Endoleak after TEVAR
Gustavo Oderich, MD, Mayo Clinic, Rochester, MN

7:54 am
Iliac Access
Andres Schanzer, MD, University of Massachusetts Medical School, Worcester MA

8:12 am
Panel Discussion

Moderators: Marc E. Mitchell, MD
University of Mississippi Medical Center, Jackson, Miss.

Robert M. Zwolak, MD
Dartmouth-Hitchcock Medical Center, Lebanon, N.H.

At the end of this session, participants should be able to:
1. Discuss the methodology, results and conclusions of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and treatment of vascular disease. 

SS28. The Use of Retrievable Inferior Vena Cava Filters in Severely Injured Trauma Patients: An Analysis with Improved Long-Term Follow-up
Owen N. Johnson, III, David L. Gillespie, Gilbert Aidinian, Paul W. White, Eric Adams, Mitchell Cox, Charles J. Fox.
Walter Reed Army Medical Center, Washington, D.C.

SS29. Late Conversion of 41 Aortic Stent Grafts
Rebecca L. Kelso, Sean P. Lyden, Brett Butler, Roy K. Greenberg, Matthew J. Eagleton, Daniel G. Clair.
Cleveland Clinic, Cleveland, Ohio.

SS30. Brachiobasilic vs. Brachiocephalic Arteriovenous Fistula: A Randomized Prospective Analysis of 100 Cases
Cuneyt Koksoy, Rojbin Karakoyun Demirci, Deniz Balci, Tuba Solak.
Ankara University Department of General Surgery Division of Vascular Surgery, Ankara, Turkey.

SS31. Operative vs. Interventional Treatment for Ostial Renal Artery Occlusive Disease: Results of a Prospective Randomized Trial
Kai M. Balzer¹, Sebastian Rossbach¹, Tomas Pfeiffer¹, Adina Voiculescu², Bernd Grabensee², Ulrich Moedder³, Wilhelm Sandmann.^1
1Department of Vascular Surgery and Kidney Transplantation, University Hospital Duesseldorf, Duesseldorf, Germany;²Department of Nephrology, University Hospital Duesseldorf, Duesseldorf, Germany;³Department of Radiology, University Hospital Duesseldorf, Duesseldorf, Germany.

SS32. Neo Aortoiliac System (NAIS) for Treating Aortic Graft Infections: Long-term Results in 187 Patients
G. Patrick Clagett¹, Ahsan T. Ali², Sophia Serrano¹, Jenny Hocking¹, J. Gregory Modrall¹, Victor D' Addio¹, Eva Scoggins¹, R. James Valentine.^1
1University of Texas Southwestern at Dallas, Dallas, Texas;²University of Arkansas for Medical Sciences, Little Rock, Ark.

Moderators: Ronald M. Fairman, MD
Hospital of the University of Pennsylvania, Philadelphia, Pa.

Nicholas J. Morrissey, MD
Columbia Presbyterian Hospital, New York, N.Y.

At the end of this session, participants should be able to:

1. Discuss the methodology, results and conclusions of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and treatment of vascular disease.

SS34. Invasive Treatment of Claudication Is Indicated for Patients Unable to Adequately Ambulate During Cardiac Rehabilitation
Sandra Spronk¹, John V. White², Connie Ryjewski², Judy Rosenblum², Johanna Bosch¹, Myriam Hunink.1
¹Erasmus University Medical Center, Rotterdam, The Netherlands;²Advocate Lutheran General Hospital, Park Ridge, Ill.

SS35. Does Surgical Intervention for Thoracic Outlet Syndrome Improve Patient’s Quality of Life?
Ricardo DeLeon, David C. Chang, Lisa Rotellini-Coltvet, Julie A. Freischlag.
Johns Hopkins School of Medicine, Baltimore, Md.

SS36. Competency of General Surgery Residents to Perform Vascular Procedures: Expectations of Vascular Surgery and General Surgery Program Directors and Trainees
Marc E. Mitchell¹, Laura R. Vick¹, Anton N. Sidawy^2,3,4, Karen R. Borman.^{1 1} University of Mississippi, Jackson, Miss.;²VA Medical Center, Washington, D.C.;³Georgetown University, Washington, D.C.;⁴George Washington University, Washington, D.C.

SS37. Increasing Number of Carotid Stenting Procedures Performed with Decreasing Mortality – The National Experience
John C. Wang¹, John Blebea¹, Paul van Bemmelen¹, Frank Schmieder¹, Michael Salvatore¹, John Gaughan.^2
1Temple University Hospital, Philadelphia, Pa.;²Temple University School of Medicine, Philadelphia, Pa.

SS38. Syndecan-1 Inhibits Growth of Abdominal Aortic Aneurysm
Jiantao Xiao, Jing Wen, Carolyn A. Haller, Elliot L. Chaikof.
Emory University, Atlanta, Ga.

Concurrent Breakout Sessions

C8: Clinical Debates 
SDCC: Room 5AB

Moderator: Frank J. Veith, MD
Cleveland Clinic Foundation, Cleveland, Ohio

At the end of this session, participants should be able to:

1. Determine the relative risks and benefits of CEA and CAS.
2. Determine the relative advantages and disadvantages of TEVAR and Open Thoracic Aneurysm Repair.
3. Be made aware of the latest level I evidence comparing CEA and CAS.

Debate 1: Best Available Therapy for Carotid Stenosis: CEA vs. CAS
CAS: Daniel Clair, MD, Cleveland Clinic Foundation, Cleveland, OH
CEA: Michel S. Makaroun, MD, Presbyterian University Hospital, Pittsburgh, PA

Debate 2: Optimal Treatment for Descending Thoracic Aortic Aneurysm in Good Risk Patients: Open Operation vs. TEVAR
Open: D. Craig Miller, MD, Stanford University School of Medicine, Stanford, CA
TEVAR: Roy K. Greenberg, MD, Cleveland Clinic, Cleveland, OH

C9: Research Forum
Clinical Implications of Basic Research in Aneurysm Pathobiology
SDCC:  Room 1AB 

Moderator: Ronald L. Dalman, MD
Stanford University School of Medicine, Stanford, Calif.  

At the end of this session, participants should be able to:

1. Understand the biologic and mechanical basis of aortic aneurysm disease.
2. Understand role of biomarkers in monitoring aneurysm disease.
3. Understand fundamental considerations for the design and conduct of clinical trials evaluating novel medical therapies.
4. Understand current concepts in molecular and cellular imaging techniques.

1:30 pm 
Inflammation, Immunity and Response to Injury: Understanding the Biologic Basis of Aortic Aneurysm Disease 
Robert W. Thompson, MD, Washington University School of Medicine, St. Louis, MO

1:42 pm 
Genetic Determinants of Thoracic and Abdominal Aortic Aneurysms
Dianna M. Milewicz, MD, PhD, The University of Texas Health Sciences Center, Houston, TX           

1:54 pm 
Integrating Biologic and Mechanical Influences on Aortic Disease
Charles A. Taylor, PhD, Stanford University, Stanford, CA   

2:06 pm 
Biomarkers and Predicting Disease Progression
Jonathan Golledge, MChir, James Cooke University, Townsville, Australia

2:18 pm 
Fundamental Considerations for Evaluating Novel Medical Therapies
B. Timothy Baxter, MD, University of Nebraska Medical Center, Omaha, NE   

2:30 pm 
Imaging Biology: Monitoring Disease and Response to Therapy
Ronald L. Dalman, MD, Stanford University School of Medicine, Stanford, CA   

2:42 pm 
Panel Discussion: Questions and Answers

C10: Peripheral Vascular Surgery Society Papers 
SDCC: Room 11AB

1:30 – 3:00 pm

At the end of this session, participants should be able to:

1. Understand the choices for imaging of vascular diseases and their limitations.
2. Appreciate the role of open and endovascular procedures for carotid therapy.
3. Review the current status and outcomes of treatment for thoracic and abdominal aneurysm.
4. Understand the management options and limitations for treatment of lower extremity occlusive disease.
5. Appraise novel therapies for vascular disease.

1:30 pm
PVSS13. Improved Outcomes Result from Multilevel Endovascular Intervention Involving the Tibial Vessels Compared to Isolated Tibial Intervention

1:45 pm
PVSS14. Is Lower Extremityrevascularization Safe in Nonagenarians?

2:00 pm
PVSS15. Left Renal Vein Transposition (LRVT) for Nutcracker Syndrome: Patient Selection, Early and Late Outcomes

2:15 pm
PVSS16. Closure Device Use Following Arterial Access Is Associated with Decreased Rate of Pseudoaneurysm Formation

2:30 pm
PVSS17. Extraanatomic Bypass vs. Endovascular Therapy in High Risk Patients with Aorto-Iliac Occlusions

2:45 pm
PVSS18. Complement Activation Leads to Systemic Inflammation After Ruptured Abdominal Aortic Aneurysm

Concurrent Breakout Sessions

C11: Research Forum—Paper Session
SDCC:  Room 1AB

Moderator: Paula Shireman, MD
University Texas Health Sciences Center, San Antonio, Texas

At the end of this session, the participant should be able to:

1. Understand the potential roles of T-cells in abdominal aortic aneurysms and atherosclerosis.
2. Gain a better understanding for the mechanism of action of cilastazol.
3. Understand the potential roles of adult stem cells and tissue-engineered grafts in vascular bypasses.  

3:30 pm
OR1. Cell Migration in Response to the Aminoterminal Fragment of Urokinase Requires Epidermal Growth Factor Receptor Transactivation Through an ADAM-mediated Mechanism
Andrew M. Bakken, Clinton D. Protack, Elisa Roztocil, Suzanne M. Nicholl, Mark G. Davies.
Methodist Debakey Heart Center, The Methodist Hospital, Houston, Texas.

3:40 pm
OR2. Interleukin 19: Critical Role in the Growth and Rupture of Aortic Aneurysms in Apolipoprotein E Deficient Mice
Venkat Kalapatapu, Angela Burke, Kyla Shelton, Nancy Rusch, Michael Edwards, John Eidt.
University of Arkansas for Medical Sciences, Little Rock, Ark.

3:50 pm
OR3. A20 Protects Against Accelerated Atherosclerosis in Aortic Allografts
Jeffrey J. Siracuse, Mark D. Fisher, Scott M. Damrauer, Lynn Y. Choi, Cleide G. Da Silva, Eva Csizmadia, Elizabeth R. Maccariello, Soizic Daniel, Christiane Ferran.
Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.

4:00 pm
OR4. Randomized Controlled Trial Assessing the Effects of Cilostazol on Exercise-Induced Ischaemia-Reperfusion in Patients with Peripheral Arterial Disease
Mark E. O'Donnell¹, Stephen A. Badger¹, Mohammed A. Sharif¹, Ragai R. Makar¹, Jane McEneny², Ian S. Young², Louis L. Lau¹, Bernard Lee¹, Raymond J. Hannon¹, Chee V. Soong.^1
1Belfast City Hospital, Belfast, United Kingdom;²Department of Medicine, Queens University Belfast, Belfast, United Kingdom.

4:10 pm
OR5. The Role of Matrix Metalloproteinases-2 and -9 in Mediating Venous Thrombus Resolution
Lornie Phillips, II¹, Erika Wong², Rajabrata Sarkar.^3
1 University of California at San Francisco - East Bay, Oakland, Calif.;²NCIRE, San Francisco, Calif.;³ University of California at San Francisco, NCIRE, San Francisco, Calif.

4:20 pm
OR6. Shear Stress Improves Adult Stem Cell Attachment to Vascular Basement Membrane Components via Upregulation of α5β1 Integrin Expression
Eric S. Hager, Neil Moudgill, Steven McIlhenny, Ping Zhang, Thomas Tulenko, Thomas Tulenko, Joseph Lombardi, Robert Larson, Paul DiMuzio.
Thomas Jefferson University Hospital, Philadelphia, Pa.

4:30 pm
OR7. A Novel Orally Active Platelet-Derived Growth Factor Receptor/Raf Pathway Inhibitor Attenuates Post-Intervention Intimal Hyperplasia
Joshua I. Greenberg, Eric Murphy, Samuel Barillas, Niren Angle, David Cheresh.
University of California, San Diego, San Diego, Calif.

4:40 pm
OR8. Neo-artery In vivo Re-growth Using a Tissue-engineered Hyaluronan Biodegradable Scaffold
Sandro Lepidi, Jr.¹, Vincenzo Vindigni, Jr.², Barbara Zavan, Jr.³, Roberta Cortivo, Sr.³, Giovanni Paolo Deriu, Sr.¹, Franco Grego, Sr.¹, Giovanni Abbatangelo, Sr.^1
1Division of Vascular Surgery, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova Medical School, Padova, Italy;²Division of Plastic Surgery, University of Padova Medical School, Padova, Italy;³Department of Histology, Microbiology and Medical Biotechnologies, University of Padova Medical School, Padova, Italy.

At the end of this session, participants should be able to:

1. Understand the choices for imaging of vascular diseases and their limitations.
2. Appreciate the role of open and endovascular procedures for carotid therapy.
3. Review the current status and outcomes of treatment for thoracic and abdominal aneurysm.
4. Understand the management options and limitations for treatment of lower extremity occlusive disease.
5. Appraise novel therapies for vascular disease.

3:30 pm           
PVSS Academic Award Report
Brian Nolan.
Dartmouth Hitchcock Medical Center, Lebanon, N.H.

3:40 pm
PVSS19. Metabolic Syndrome: A Predictor of Adverse Outcomes After Carotid Revascularization?

3:55 pm
PVSS20. Duplex-Derived Access Volume Flow (DAVQ): A Novel Predictor of Success Following Endovascular Repair of Failing or Non-Maturing Arterial-Venous Fistulas (AVF) for Hemodialysis

4:10 pm
PVSS21. Improved Outcomes in Mildly Obese Vascular Surgery Patients: The Obesity Paradox

4:25 pm
PVSS22. The Brachial Artery: A Critical Access for Complex Endovascular Procedures

4:40 pm
PVSS23. Chest and Abdominopelvic CT Scans Are Important Tools for Evaluating Patients with Iliofemoral Venous Thrombosis

4:55 pm
PVSS24. Bleeding Increases the Risk for Major Ischemic Events in Patients with Peripheral Arterial Disease Using Antithrombotic Treatments

C13: Surgical Outcomes: A Contemporary Perspective
Sponsored by the SVS Committee on Women’s Issues
SDCC: Room 2

Moderator: Cynthia K. Shortell, MD
Duke University Medical Center, Durham, NC

At the end of this session, participants should be able to:

1. Define the terms "quality of care, "cost of care,” "efficiency of care" and "value purchasing."
2. Describe the pay-for-performance initiatives for both hospitals and physicians.
3. Recognize the impact of the SGR structural problem will be explored as it affects physician reimbursement.
4. Define surgical outcomes of hospital reimbursement as it relates to costs and the various margins.

3:30 - 5:00 pm
Michael Abecassis, MD, MBA
Feinberg School of Medicine, Northwestern University, Chicago, IL           

Moderators: George L. Berdejo, RVT, FSVU
Montefiore Medical Center, Bronx, N.Y.

John F. Eidt, MD
University of Arkansas for Medical Sciences, Little Rock, Ark.

At the end of this session, participants should be able to:

1. Discuss the role of CT/MRA in the follow-up of aortic endografts.
2. Identify the current uses of pressure sensing devices in the post-operative imaging of aortic grafts.
3. Recognize the benefits and drawbacks associated with the use of contrast enhancing agents during the performance of duplex ultrasound.
4. Identify the technical details of duplex ultrasound examination of aortic endografts.

3:30 pm
Current Role of CT/MRA in Post-Op Follow-up of Aortic Endograft
Martin R. Back, MD, University of South Florida, Tampa, FL

3:42 pm
Color-Flow Duplex Ultrasound After Aortic Endografts
Noel Parent, MD, Vascular and Transplant Specialists, Virginia Beach, Va.

3:54 pm   
The Role of Contrast Enhanced Duplex Ultrasound in Post-Operative Monitoring of AAA Endografts
Peter H. Lin, MD, Baylor College of Medicine, Houston, Texas

4:06 pm
Basic EVAR Assessment Protocol by Ultrasound
George L. Berdejo, RVT, FSVU, Montefiore Medical Center, Bronx, N.Y.

4:18 pm
EVAR: Troubleshooting by Ultrasound
Bonnie L. Johnson, RDMS, RVT, FSVU, Stanford University Bioengineering & School of Medicine, Stanford, Calif.

4:30 pm
Pressure Sensing Devices in the Follow-up of Aortic Endografts
Ross Milner, MD, Emory University Hospital, Atlanta, Ga.

4:42 pm
Panel Discussion

C15: Research Forum—Poster Session and Reception
Reception sponsored by The American Vascular Association
SDCC: Room 7AB

Moderator: Barry Rubin, MD
Toronto General Hospital, Toronto, ON

At the end of this session, participants should be able to:

1. Discuss thc134e methodology, results and conclusions of the research presented in vascular health.
2. Gain knowledge of new technology for diagnosis and treatment of vascular disease.

5:15 pm
PR1. The Atheroprotective Molecule A20 Inhibits Post-Angioplasty Restenosis by Both Anti-Inflammatory and Anti-Angiogenic Pathways
Scott M. Damrauer^1,2, Mark D. Fisher¹, Salvatore T. Scali¹, Hiromi Wada¹, Cleide G. ^da Silva¹, Eva Csizmadia¹, Elizabeth R. Maccariello¹, Karam Moon¹, Jeffery J. Siracuse¹, Robert Bolash¹, William Aird¹, Soizic Daniel¹, Christiane Ferran.^1
1Beth Israel Deaconess Medical Center, Boston, Mass.;²Massachusetts General Hospital, Boston, Mass.

5:20 pm
PR2. Long-Term Histological Effects of Oversizing Self Expanding Nitinol Stents Implanted in the Peripheral Arteries of a Porcine Model
H. Zhao¹, A. Nikanorov¹, R. Virmani², R. Jones², E. Pacheco2, L.B. Schwartz.^1
1Abbott Vascular, Santa Clara, Calif.;²CVPath, Gaithersburg, Md.

5:25 pm
PR3. Longitudinal Mechanical Stresses in Carotid Plaques of Symptomatic Patients
Samuel A Kock¹, Jens Nygaard², Søren Dalager³, Minako Oikawa⁴, Chun Yuan⁴, Nikolaj Eldrup⁵, Anette Klærke⁵, William Paaske⁵, Won Y. Kim.^6,1
1Aarhus University Hospital Skejby, Aarhus N, Denmark;²Interdisciplinary Nano Center, Aarhus University, Aarhus N, Denmark;³Department of Pathology, Aarhus University Hospital Skejby, Aarhus N, Denmark;⁴Vascular Imaging Lab, University of Washington, Seattle, Wash.;⁵Department. of Cardiothoracic and Vascular Surgery, Aarhus University Hospital Skejby, Aarhus N, Denmark;⁶Department of Cardiology, Aarhus University Hospital Skejby, Aarhus N, Denmark.

5:30 pm
PR4. Activation of Notch1 Signaling in Fibroblasts Inhibits Interlukin (IL)-6 Production Whereby Proliferation, Migration and Support of Vascular Tube Formation Are Regulated
Zhao-Jun Liu.
University of Miami, Miami, Fla.

5:35 pm
PR6. Sarpogrelate Hydrochloride Reduced Intimal Hyperplasia in Experimental Rabbit Vein Graft-Possible Involvement of Enhancement of Nitric Oxide (NO) Production
Akio Kodama¹, Akihito Idetsu¹, Masayuki Sugimoto¹, Tsutomu Ihara¹, Kiyoaki Niimi¹, Hiroshi Narita¹, Masayoshi Kobayashi¹, Kiyohito Yamamoto¹, Takeo Itoh², Kimihiro Komori.^1
1Division of Vascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan;²Department of Cellular and Molecular Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.

5:40 pm
PR8. Aptitude Predicts Endovascular Performance of Inexperienced Individuals Before and After Virtual Reality Training
Isabelle Van Herzeele^1,2, Kevin O'Donoghue¹, Rajesh Aggarwal¹, Frank Vermassen², Ara Darzi¹, HHG Eastcott³, Nicholas Cheshire.^1,3
1Imperial College London, London, United Kingdom;²Ghent University Hospital, Ghent, Belgium;³Regional Vascular Unit, London, United Kingdom.

5:45 pm
PR9. Elevated Serum Cystatin C Is Associated with Increased Mortality in Patients with Peripheral Arterial Occlusive Disease
Grazina Urbonaviciene¹, Guo-Ping Shi², Eskild W Henneberg¹, Jes S Lindholt.^1
1Vascular Research Unit, Department of Vascular Surgery, Viborg Hospital, Viborg, Denmark;²Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

5:50 pm
PR10. Preclinical Evaluation of an Autologous Stem Cell-Based Tissue-Engineered Vascular Graft in a Pig Model
Navyash Gupta, Lorenzo Soletti, Alejandro Nieponice, Burhan Gharaibeh, Gerhardt Konig, Jianjun Guan, Yi Hong, Johnny Huard, William R. Wagner, David A. Vorp.
University of Pittsburgh, Pittsburgh, Pa.

5:55 pm
PR11. Inhalation of Carbon Monoxide Reduces Skeletal Muscle Injury Following Hind Limb Ischemia/Reperfusion
Rajendra Patel, Hassan Albadawi, Jeanwan Kang, Hyung-Jin Yoo, Faraz F. Hashmi, Glenn M. LaMuraglia, Michael T. Watkins.
Massachusetts General Hospital, Boston, Mass.

6:00 pm
PR12. Nitric Oxide Decreases Neointimal Hyperplasia via Differential Regulation of Reactive Oxygen Species Throughout the Arterial Wall
Daniel A. Popowich, Janet Martinez, Vanessa R. Lee, Jozef Murar, Samer F. Najjar, Qun Jiang, Christopher P. Walsh, Melina R. Kibbe.
Northwestern University, Chicago, Ill.

6:05 pm
PR13. Does the Aorta Expand Elliptically? Shape Changes Analyzed and Visualized with Dynamic MRI
Joffrey van Prehn¹, Joost A. van Herwaarden¹, Koen L. Vincken², Bart E. Muhs³, Hence J. M. Verhagen^1,4, Frans L. Moll1, Lambertus W. Bartels.2
1University Medical Center, Utrecht, The Netherlands;2Image Sciences Institute, University Medical Center, Utrecht, The Netherlands;3Yale University School of Medicine, New Haven, Conn.;4Erasmus University Medical Center, Rotterdam, The Netherlands.

6:10 pm
PR14. Greater Saphenous Vein Is a Novel Source of Endothelial Colony Forming Cells
Richard Ofstein, Janak Bhavsar, Reza Saadatzadeh, Michael C. Dalsing, Shaoib Shafique, Michael P. Murphy.
Indiana University, Indianapolis, Ind.

6:15 pm
PR15. Challenging Venous Outflow with Reactive Hyperemia to Detect Obstruction in Postthrombotic Venous Disease
David J. Paolini, Linda S. Jones, Anthony J Comerota.
The Toledo Hospital, Toledo, Ohio.

6:20 pm
PR7. Expression Profiles of Angiogenesis-Related Genes in Skeletal Muscle from Young and Old Mice Following Acute Hindlimb Ischemia
Jinsong Wang, Xia Liu, Lee Alderman, Justin Tilan, Remi Adenika, James Andrews, Epstein E Stephen, Mary Susan Burnett
MedStar Research Institute, Washington DC